OUR DOCTORS

2

Julius B.-M. Anang (MD, PhD, FRCPC)
Neurologist with Special Interest in
Movement Disorders

Office Telephone: (204) 925-9539   Fax Number: (204) 231-2283

juliusAnang pic

Availability:  Appointment by Consultation Only
Medical School: Johannes Gutenberg University Mainz, Germany
Neurology residency:  University of Saskatchewan, University of Manitoba
Movement Disorders Fellowship: McGill University, Montreal, Canada
Others:   Postgraduate Studies in Internal Medicine: Charite Berlin, Germany
Languages:  English, French and German (consultations in any of these languages)
 

Clinical Interest:

Diagnosis and management of movement disorders

–     Parkinson disease and Parkinson-like disorders

Including advanced therapies such as continuous levodopa-carbidopa intestinal gel infusion therapy

–     Dystonia, tremor, ataxia, tics, myoclonus, chorea

–     Botulinum toxin injection therapy for movement disorders

–     Dyskinesias and drug-induced movement disorders etc.

–     Neurological aspects of sleep disorders including sleep related movement disorders

–     Selected areas of general neurology

 

Research Interests:

Diagnosis and management of motor and non-motor symptoms /complications of Parkinson disease.

Peer-reviewed Publications:

1. Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D and Lang AE. Caffeine as a Treatment for Parkinson’s Disease (Café-PD):  A Randomized Controlled Trial. Submitted to Neurology (2017).

2. Anang JBM, Nomura T, Romenets SR, Nakashima K, Gagnon JF, Postuma RB. Dementia Predictors in Parkinson Disease: A Validation Study. J Parkinson’s Disease 2017; 7(1) 159 -162. Doi:http://dx.doi.org/10.3233/JPD-160925

3. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol. 2015 Aug;72(8):863-73.

Doi: http://dx.doi.org/10.1001/jamaneurol.2015.0703

4. Romenets SR, Anang J, Fereshtehnejad SM, Pelletier A, Postuma RB. Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: A Randomized control study. Complementary Therapies in Medicine 2015; 23:175-184. Doi:http://dx.doi.org/10.1016/j.ctim.2015.01.015

5. Kawada T, Anang JB, Postuma R. Predictors of dementia in Parkinson disease: A prospective cohort study. Author response. Neurology 2015; 84(12): 1285-6.

Doi: http://dx.doi.org/10.1212/WNL.0000000000001408

6. Anang JB, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J,

Postuma RB. Predictors of dementia in Parkinson disease: A prospective cohort study. Neurology 2014; 83(14): 1253-60 Doi:  http://dx.doi.org/10.1212/WNL.0000000000000842

7. Anang J and Tellez-Zenteno JF (2012). Single Unprovoked Seizure: Wait Time to Full Medical Assessment, Does it Matter? Neurol. Bull. 2012; 4: 1 – 11

Doi: http://dx.doi.org/10.7191/neurol_bull. 2012.1035

Published Manuscripts and books:

  1. Co-author.  Basic and Clinical Research Update in Parkinson’s disease. Highlights from the 4th World Parkinson Congress 2016: A Canadian Perspective. September 20-23, Portland, Oregon, USA. Approved by the Schulich School of Medicine and Dentistry, University of Western Ontario, Canada.
  2. Parkinson’s Disease: An Introductory Guide (patient education)Ron Postuma and Julius Anang

 

SiteLock